Innovation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IPIX and buy or sell other stocks, ETFs, and their options commission-free!

About IPIX

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. 

CEO
Leo Ehrlich
CEOLeo Ehrlich
Employees
4
Employees4
Headquarters
Wakefield, Massachusetts
HeadquartersWakefield, Massachusetts
Founded
2007
Founded2007
Employees
4
Employees4

IPIX Key Statistics

Market cap
376.10K
Market cap376.10K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
103.42K
Average volume103.42K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 376.1K, Innovation Pharmaceuticals(IPIX) trades at $0.00.

On 2026-03-31, Innovation Pharmaceuticals(IPIX) stock opened at —, reached a high of —, and a low of —.

The Innovation Pharmaceuticals(IPIX)'s current trading volume is 0, compared to an average daily volume of 103.42K.

In the last year, Innovation Pharmaceuticals(IPIX) shares hit a 52-week high of $0.05 and a 52-week low of $0.00.

In the last year, Innovation Pharmaceuticals(IPIX) shares hit a 52-week high of $0.05 and a 52-week low of $0.00.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.